These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 3214906

  • 21. [Ultrasonic decompression of malignant ocular hypertension secondary to traumatic hyphema].
    Jebejian R, Kechichian A.
    J Fr Ophtalmol; 1983; 6(2):129-33. PubMed ID: 6863825
    [Abstract] [Full Text] [Related]

  • 22. Management of the failing glaucoma filter.
    Shingleton BJ.
    Ophthalmic Surg Lasers; 1996 Jun; 27(6):445-51. PubMed ID: 8782258
    [No Abstract] [Full Text] [Related]

  • 23. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma.
    Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN.
    Am J Ophthalmol; 2004 Sep; 138(3 Suppl):S19-31. PubMed ID: 15364049
    [Abstract] [Full Text] [Related]

  • 24. Management of patients with ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
    Rosenbaum LJ.
    Am J Ophthalmol; 2007 Jan; 143(1):191-2; author reply 192-3. PubMed ID: 17188074
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Ocular pressure varying from 18 to 24 mmHg in a 50-year-old patient: surveillance and treatment].
    J Fr Ophtalmol; 1993 Jan; 16(11):644-8. PubMed ID: 8169316
    [No Abstract] [Full Text] [Related]

  • 32. [Treatment of ocular hypertension after trabeculectomy].
    J Fr Ophtalmol; 1995 Jan; 18(10):645-8. PubMed ID: 8568171
    [No Abstract] [Full Text] [Related]

  • 33. Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.
    Coleman AL, Gordon MO, Beiser JA, Kass MA, Ocular Hypertension Treatment Study.
    Am J Ophthalmol; 2004 Oct; 138(4):684-5. PubMed ID: 15488816
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D, Călugăru M.
    Oftalmologia; 2009 Oct; 53(3):15-33. PubMed ID: 19899544
    [Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of treating ocular hypertension.
    Stewart WC, Stewart JA, Nasser QJ, Mychaskiw MA.
    Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Situation with glaucoma and the state of mind in the glaucoma community.
    Kotik J.
    J Glaucoma; 1998 Dec; 7(6):446-7. PubMed ID: 9871870
    [No Abstract] [Full Text] [Related]

  • 39. [Glaucoma, ocular hypertension and diabetic retinopathy].
    Klemen UM, Biber B, Frey C, Gnad HD.
    Wien Klin Wochenschr; 1985 Aug 09; 97(15):616-9. PubMed ID: 4049884
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.